25434876|t|Proteasome inhibitor-induced autophagy in PC12 cells overexpressing A53T mutant alpha-synuclein.
25434876|a|The aim of the present study was to examine the effects of proteasome inhibitor (PI)-induced autophagy on PC12 cells overexpressing A53T mutant alpha-synuclein (alpha-syn) by detecting alterations in the levels of microtubule-associated protein 1A/1B light chain (LC3)+ autophagosomes and the lysotracker-positive autolysosomes using immunofluorescence, the expression of LC3-II using western blot analysis and the morphology of PC12 cells using transmission electron microscopy. It was found that the addition of MG132 (500 nmol/l) significantly increased the number of autophagosomes and autolysosomes and upregulated the expression of LC3-II. The autophagy inhibitor 3-methyladenine (3-MA) completely inhibited the autophagy induced by MG132 (500 nmol/l). The autophagy enhancer trehalose significantly increased the number of autophagosomes and autolysosomes and improved the protein level of LC3-II induced by MG132. To examine the effect of PI-induced autophagy on the degradation of A53T mutant alpha-syn, the expression of alpha-syn was detected by western blot analysis. It was revealed that MG132 increased the expression of A53T alpha-syn and trehalose counteracted the increase of A53T alpha-syn induced by MG132. Combined inhibition of 3-MA and PI significantly increased the accumulation of A53T alpha-syn as compared with treatment using either single agent. In addition, combination of MG132 (500 nmol/l) with trehalose (50 mmol/l) or 3-MA (2 mmol/l) markedly decreased the cell viability as compared with treatment using either single agent individually as demonstrated using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. These results suggest that the PI, MG132, could induce autophagy in PC12 cells overexpressing A53T mutant alpha-syn and this autophagy could be completely inhibited by 3-MA, indicating that PI-induced autophagy is mediated by the upregulation of the macroautophagy class III PI3K pathway. PI-induced autophagy may act as a compensatory degradation system for degradation of A53T alpha-syn when the ubiquitin-proteasome system is impaired. Autophagy activation may directly contribute to the survival of PC12 cells treated with proteasome inhibitors. The present study may assist in illuminating the association between PI and autophagy in the pathogenesis of Parkinson's disease.
25434876	42	46	PC12	CellLine	CVCL:0481
25434876	68	72	A53T	ProteinMutation	tmVar:p|SUB|A|53|T;HGVS:p.A53T;VariantGroup:0;OriginalGene:29219;CorrespondingGene:6622;RS#:104893877;CorrespondingSpecies:10116;CA#:257068
25434876	80	95	alpha-synuclein	Gene	29219
25434876	203	207	PC12	CellLine	CVCL:0481
25434876	229	233	A53T	ProteinMutation	tmVar:p|SUB|A|53|T;HGVS:p.A53T;VariantGroup:0;OriginalGene:29219;CorrespondingGene:6622;RS#:104893877;CorrespondingSpecies:10116;CA#:257068
25434876	241	256	alpha-synuclein	Gene	29219
25434876	361	364	LC3	Gene	25291
25434876	390	401	lysotracker	Chemical	MESH:C493330
25434876	469	475	LC3-II	Gene	362245
25434876	526	530	PC12	CellLine	CVCL:0481
25434876	611	616	MG132	Chemical	MESH:C072553
25434876	735	741	LC3-II	Gene	362245
25434876	767	782	3-methyladenine	Chemical	MESH:C025946
25434876	784	788	3-MA	Chemical	MESH:C025946
25434876	836	841	MG132	Chemical	MESH:C072553
25434876	879	888	trehalose	Chemical	MESH:D014199
25434876	994	1000	LC3-II	Gene	362245
25434876	1012	1017	MG132	Chemical	MESH:C072553
25434876	1087	1091	A53T	ProteinMutation	tmVar:p|SUB|A|53|T;HGVS:p.A53T;VariantGroup:0;OriginalGene:29219;CorrespondingGene:6622;RS#:104893877;CorrespondingSpecies:10116;CA#:257068
25434876	1198	1203	MG132	Chemical	MESH:C072553
25434876	1232	1236	A53T	ProteinMutation	tmVar:p|SUB|A|53|T;HGVS:p.A53T;VariantGroup:0;OriginalGene:29219;CorrespondingGene:6622;RS#:104893877;CorrespondingSpecies:10116;CA#:257068
25434876	1251	1260	trehalose	Chemical	MESH:D014199
25434876	1290	1294	A53T	ProteinMutation	tmVar:p|SUB|A|53|T;HGVS:p.A53T;VariantGroup:0;OriginalGene:29219;CorrespondingGene:6622;RS#:104893877;CorrespondingSpecies:10116;CA#:257068
25434876	1316	1321	MG132	Chemical	MESH:C072553
25434876	1346	1350	3-MA	Chemical	MESH:C025946
25434876	1402	1406	A53T	ProteinMutation	tmVar:p|SUB|A|53|T;HGVS:p.A53T;VariantGroup:0;OriginalGene:29219;CorrespondingGene:6622;RS#:104893877;CorrespondingSpecies:10116;CA#:257068
25434876	1499	1504	MG132	Chemical	MESH:C072553
25434876	1523	1532	trehalose	Chemical	MESH:D014199
25434876	1548	1552	3-MA	Chemical	MESH:C025946
25434876	1692	1752	3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide	Chemical	MESH:C022616
25434876	1795	1800	MG132	Chemical	MESH:C072553
25434876	1828	1832	PC12	CellLine	CVCL:0481
25434876	1854	1858	A53T	ProteinMutation	tmVar:p|SUB|A|53|T;HGVS:p.A53T;VariantGroup:0;OriginalGene:29219;CorrespondingGene:6622;RS#:104893877;CorrespondingSpecies:10116;CA#:257068
25434876	1928	1932	3-MA	Chemical	MESH:C025946
25434876	2134	2138	A53T	ProteinMutation	tmVar:p|SUB|A|53|T;HGVS:p.A53T;VariantGroup:0;OriginalGene:29219;CorrespondingGene:6622;RS#:104893877;CorrespondingSpecies:10116;CA#:257068
25434876	2263	2267	PC12	CellLine	CVCL:0481
25434876	2419	2438	Parkinson's disease	Disease	MESH:D010300
25434876	Negative_Correlation	MESH:D014199	RS#:104893877;HGVS:p.A53T;CorrespondingGene:6622
25434876	Association	MESH:D010300	RS#:104893877;HGVS:p.A53T;CorrespondingGene:6622
25434876	Positive_Correlation	MESH:C025946	RS#:104893877;HGVS:p.A53T;CorrespondingGene:6622
25434876	Positive_Correlation	MESH:C072553	RS#:104893877;HGVS:p.A53T;CorrespondingGene:6622
25434876	Positive_Correlation	MESH:D014199	362245
25434876	Positive_Correlation	MESH:C072553	362245
25434876	Negative_Correlation	MESH:C072553	MESH:D014199
25434876	Negative_Correlation	MESH:C025946	MESH:C072553
25434876	Association	MESH:D010300	6622

